feature photo

Feature Article #1

Find Patients Lost To Follow-Up

OmniTrace Corp. - The Patient Search Experts.  We maximize clinical trial success by greatly reducing patients Lost To Follow-Up.  We find patients and clinical trial participants who become missing anywhere in the world.  In addition to our patient locate service, we offer

admin | July 13th, 2008 | Continued

About this Site

Who is OmniTrace?
OmniTrace Corp., located in Boca Raton, Florida is the nation’s premier patient locate service.   We improve clinical trial results by greatly reducing patients who are lost to follow-up.

Other Recent Articles

Addressing Clinical Trial Recruitment and Retention Issues Imposed by HIPAA Step by Step (first of a series)

Recent reports indicate that the Health Insurance Portability and Accountability Act (HIPAA) that went into effect in 2003 has adversely affected clinical trial conduct by (a) increasing researchers’ administrative burden; (b) increasing overall trial conduct costs; (c) delaying initial project approval; (d) hampering medical record and registry research, and most critical; (e) impeding clinical trial recruiting and retention,1 which in turn has deterred locating patients lost-to-follow-up (LTFU).

Subsequent to our recent post that focused on these factors that hinder the conduct of clinical trials as a consequence of the HIPAA, this commentary will serve as the first of several that will discuss strategies to enhance recruitment, retention, and finding patients LTFU based on

Prevent Lost To Follow-Up With OmniTrace’s Patient Locator Service

Patient Locator Patient Locator

Our OmniTrace patient locator division has located well over five thousand patients who were at one point considered lost to follow-up.

Finding missing people is all we do (well almost).  We have located tens of thousands of people including:  clinical trial patients, lost friends, military personnel, lost loves, classmates, debtors, dead beat parents, missing heirs, lost family members and persons in hiding. 

Here are a few reasons why you should consider OmniTrace as your patient locator provider:

Impact Of HIPAA On Clinical Trial Conduct

Clinical Trial ConductClinical Trial Conduct

Assuring full compliance of guidelines mandated by governing authorities is critical to conducting successful clinical trial research and to subsequent product approval.  The federal government’s medical privacy rule, the Health Insurance Portability and Accountability Act (HIPAA), that went into effect in 2003 is such a mandate.  It has greatly impacted the conduct of clinical trials, however, not in a favorable way.  The focus of this post is to highlight various factors that have hindered the conduct of clinical trials as a consequence of rules imposed by HIPAA.

HIPAA of 1996 included a major provision that required

Find Patient | Find Patient Fast - Improve Clinical Trial Retention

Patient Find

Patient Recruiters, Principal Investigators and Study Coordinators can greatly improve clinical trial retention and reduce patients lost to follow-up by simply obtaining more contact information when the patient is first recruited into a study.  Detailed contact information will allow a search company, such as OmniTrace, many more avenues to find a patient in the event the patient becomes lost. 

We suggest you request the following information when enlisting a new patient for

Efficiency of Clinical Trials Require Effective Recruitment, Retention and Return

Efficiency Of Clinical TrialsEfficiency of Clinical Trials

Conducting clinical trials is becoming increasingly arduous for drug manufactures due to several factors including: (a) heightened food and drug (FDA) regulatory scrutiny based on recent safety concerns; (b) inefficiencies and/or unclear guidance imposed by Health Insurance Portability and Accountability Act (HIPAA) guidelines in the research, design, enrollment and follow-up processes; (c) and increased demand and competition for patients due to a plethora of investigational products under study, as well as the increased scope and design of studies.1 

An obvious critical determinant of successful clinical trial research and subsequent product approval is to assure full compliance of regulatory/guidelines mandates of governing authorities throughout the entire clinical process. Other key determinants associated with the success and efficiency of clinical trials are recruitment, retention2 and return, especially when

Clinical Trial Recruitment | Retention Issues for Manufacturers of Diabetes Agents

Clinical Trial Recruitment | Retention

Anxiety lurks among manufacturers of type 2 diabetes drugs, especially those manufacturers who have drugs in late clinical development. 

Recent FDA advisory committee recommendations have created an ongoing debate over whether Investigational diabetes agents should be subject to long-term cardiovascular safety. 1   A firm consensus has not been reached,  however, several manufacturers are already scurrying to develop plans and design studies addressing impending implications of a

OmniTrace Patient Locate Services

Patient Locate

Patient Locate

We’d like to provide you additional information about OmniTrace Corp. and our patient locate services. 

Who Are We?

OmniTrace Corporation, a licensed and bonded private investigation agency, headquartered in Boca Raton, Florida, established in 2001, is the premier patient locate service provider to the clinical trial industry.

In the USA, Europe, South America and elsewhere, OmniTrace locates Lost To Follow-Up patients required to

HIPAA: Clinical Study Conduct When Searching For Patients Lost To Follow-Up

Much information exists about HIPAA–a multifaceted legislation covering the insurance portability and fraud enforcement (accountability) acts.  However, the guidance for privacy and security laws are vague, particularly regarding:

  • Clinical study conduct and searching for patients that have prematurely dropped out and are lost to follow-up
  • How HIPAA affects long-term follow-up (pharmacovigilance) programs encourage by the FDA for subjects in clinical trials

OmniTrace Corp. has expended considerable effort to clarify

Bad Behavior has blocked 40 access attempts in the last 7 days.